Affiliate disclosure: This article contains affiliate links. If you buy through them, we may earn a commission at no extra cost to you. This does not influence our assessment of the evidence below.
Evidence rating: Moderate for the gut side, Preliminary for the skin side — the probiotic has repeatable trials; the skin story rests on newer and partly indirect data
What Neotonics Claims To Be
Neotonics is a chewable gummy built on the “gut-skin axis” idea: that the state of your digestive microbiome influences skin turnover, inflammation, and visible aging. Rather than putting something on your face, the pitch is to change what’s happening in your gut and let the skin follow.
The axis itself is a real and actively researched concept, not a marketing fiction. Whether a specific gummy moves the needle on it is a separate question, and it’s the one worth answering.
What’s Actually In It
Neotonics discloses 500 million CFU of Bacillus coagulans per serving, alongside nine named botanicals:
- Babchi (Psoralea corylifolia, the plant source of bakuchiol)
- Inulin and dandelion
- Fenugreek
- Lemon balm
- Organic Ceylon ginger
- Slippery elm bark
- Organic lion’s mane
- Fennel
Two observations up front. First, every plant is actually named, which is more transparency than a lot of this category offers and lets you check the list against your own allergies. Second, 500 million CFU is on the low side — many B. coagulans trials run at 2 billion spores per day or higher, which is four times this dose. And the individual botanical amounts aren’t published.
What The Research Shows
According to PubMed, Bacillus coagulans is the best-evidenced thing in this formula, and its evidence is about digestion rather than complexion.
It reduced gas and bloating in a placebo-controlled trial. Seventy adults with functional gas and bloating were randomized to B. coagulans MTCC 5856 at 2 billion spores/day or placebo for four weeks. Indigestion scores in the probiotic group fell from 8.91 to 3.06, versus a non-significant change in placebo, and patient global evaluation scores improved sharply. No adverse events were reported. DOI
It outperformed placebo in a functional dyspepsia trial published in a Lancet journal. In a randomized, double-blind, placebo-controlled study at University Hospitals Leuven, 68 patients received either spore-forming probiotics (B. coagulans MY01 plus B. subtilis MY02) or placebo for eight weeks. The clinical response rate was 48% on probiotics versus 20% on placebo — a relative risk of 1.95. Adverse events were no more common than with placebo. DOI00226-0)
A third trial found benefit for IBS symptoms — with one negative result inside it. In a 12-week randomized, double-blind, multicenter trial of 100 participants, B. coagulans BCP92 significantly improved IBS severity, gastrointestinal symptom frequency, stool consistency, and stress. Worth noting honestly: interleukin-6, the inflammatory marker the researchers measured, showed no significant change — so the symptom improvements were not matched by movement in that biomarker. DOI
On the skin claim, the closest direct evidence is encouraging and small. An 8-week randomized, double-blind, placebo-controlled study of 36 participants tested an oral antioxidant-rich synbiotic (probiotic plus prebiotic — the same architecture as this gummy’s probiotic-plus-inulin design). At week 8 the treatment group showed a significant reduction in wrinkle severity of 5.28%, along with significant gains in cheek elasticity and firmness, while placebo showed no significant change on those measures. The effect sizes are small and the sample is small, but the direction is real. DOI
The babchi caveat is the important one. Bakuchiol, the active compound in babchi, has a well-regarded 12-week randomized double-blind trial in 44 patients showing it matched 0.5% retinol for reducing wrinkle surface area and hyperpigmentation, with fewer side effects. That’s a genuinely good result — but it was a cream applied to the face twice daily. It says nothing about swallowing babchi in a gummy, and no one should let the reputation of topical bakuchiol transfer silently to an oral product. DOI
The Honest Verdict
What holds up: Bacillus coagulans is a legitimately useful probiotic with several independent randomized trials behind it for bloating, dyspepsia, and IBS symptoms, plus a clean safety record — and being spore-forming, it actually survives stomach acid, which many probiotics do not. Inulin is a well-characterized prebiotic. Ginger, fennel, and slippery elm have long, plausible histories in digestive comfort. If you buy this for your gut, you’re on defensible ground.
What doesn’t: The dose. 500 million CFU is a quarter of what the bloating trial used, and dose matters for probiotics. The skin case is the weaker half of the pitch: the one directly relevant oral trial is 36 people over 8 weeks showing a 5% wrinkle change, and the headline botanical’s best evidence comes from a topical cream, not an ingestible. Lion’s mane and lemon balm are researched for cognition and mood rather than skin. Nobody should expect this to work like a dermatology product.
Who this makes sense for: Someone whose main complaint is digestive — bloating, irregularity, post-meal discomfort — who is intrigued by the possibility of secondary skin benefits but isn’t buying on that basis. If you find capsules unpleasant, a gummy format is a real practical advantage for adherence.
Who should skip it: Anyone buying it primarily as a wrinkle treatment; topical bakuchiol or a retinoid has far better evidence for that and costs less. Also anyone immunocompromised (live-organism products warrant a doctor’s sign-off), anyone pregnant — babchi/Psoralea is not established as safe in pregnancy — and anyone with a diagnosed skin condition, which is a dermatologist’s call rather than a supplement’s.
Check current pricing and availability
View Neotonics on the official site
This article is for informational purposes only and is not medical advice. Dietary supplements are not intended to diagnose, treat, cure, or prevent any disease. These statements have not been evaluated by the Food and Drug Administration. Talk to your physician or dermatologist before starting any supplement, especially if you have a diagnosed condition or take medication.
Research cited via PubMed:
- Majeed M, et al. Medicine (Baltimore). 2023;102(9):e33109. DOI
- Wauters L, et al. Lancet Gastroenterol Hepatol. 2021;6(10):784-792. DOI00226-0)
- Shaikh SS, Kumar S. Medicine (Baltimore). 2024;103(31):e39134. DOI
- Afzal L, et al. J Cosmet Dermatol. 2026;25(4):e70836. DOI
- Dhaliwal S, et al. Br J Dermatol. 2019;180(2):289-296. DOI